{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:42:34Z","timestamp":1787020954732,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2021YFC2301801"],"award-info":[{"award-number":["2021YFC2301801"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272313"],"award-info":[{"award-number":["82272313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02502-w","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:40:48Z","timestamp":1744155648000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["USP21 is involved in the development of chronic hepatitis B by modulating the immune microenvironment"],"prefix":"10.1186","volume":"30","author":[{"given":"Pengyu","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"10","key":"2502_CR1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/S0969-2126(01)00237-4","volume":"3","author":"JM Kenney","year":"1995","unstructured":"Kenney JM, von Bonsdorff CH, Nassal M, Fuller SD. Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores. Structure. 1995;3(10):1009\u201319. https:\/\/doi.org\/10.1016\/S0969-2126(01)00237-4.","journal-title":"Structure"},{"issue":"4","key":"2502_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"Global Burden of Disease Cancer Collaboration","year":"2017","unstructured":"Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524\u201348. https:\/\/doi.org\/10.1001\/jamaoncol.2016.5688.","journal-title":"JAMA Oncol"},{"issue":"5","key":"2502_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","volume":"17","author":"O Krenkel","year":"2017","unstructured":"Krenkel O, Tacke F. Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol. 2017;17(5):306\u201321. https:\/\/doi.org\/10.1038\/nri.2017.11.","journal-title":"Nat Rev Immunol"},{"key":"2502_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.636897","author":"J Zhang","year":"2021","unstructured":"Zhang J, Ling N, Lei Y, Peng M, Hu P, Chen M. Multifaceted interaction between hepatitis B virus infection and lipid metabolism in hepatocytes: a potential target of antiviral therapy for chronic hepatitis B. Front Microbiol. 2021. https:\/\/doi.org\/10.3389\/fmicb.2021.636897.","journal-title":"Front Microbiol"},{"issue":"1","key":"2502_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","volume":"1","author":"LG Guidotti","year":"2006","unstructured":"Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol Mech Dis. 2006;1(1):23\u201361. https:\/\/doi.org\/10.1146\/annurev.pathol.1.110304.100230.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"5","key":"2502_CR6","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","volume":"16","author":"A Schurich","year":"2016","unstructured":"Schurich A, Pallett LJ, Jajbhay D, et al. Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host. Cell Rep. 2016;16(5):1243\u201352. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.078.","journal-title":"Cell Rep"},{"key":"2502_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2021.100973","volume":"82","author":"H Qian","year":"2021","unstructured":"Qian H, Chao X, Williams J, et al. Autophagy in liver diseases: a review. Mol Aspects Med. 2021;82: 100973. https:\/\/doi.org\/10.1016\/j.mam.2021.100973.","journal-title":"Mol Aspects Med"},{"issue":"2","key":"2502_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbrc.2014.10.076","volume":"454","author":"J Deng","year":"2014","unstructured":"Deng J, Huang Q, Wang Y, et al. Hypoxia-inducible factor-1alpha regulates autophagy to activate hepatic stellate cells. Biochem Biophys Res Commun. 2014;454(2):328\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2014.10.076.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"2502_CR9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/v9080230","volume":"9","author":"S Lin","year":"2017","unstructured":"Lin S, Zhang YJ. Interference of apoptosis by hepatitis B virus. Viruses. 2017;9(8):230. https:\/\/doi.org\/10.3390\/v9080230.","journal-title":"Viruses"},{"issue":"25","key":"2502_CR10","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.4254\/wjh.v8.i25.1061","volume":"8","author":"CCK Chao","year":"2016","unstructured":"Chao CCK. Inhibition of apoptosis by oncogenic hepatitis B virus X protein: implications for the treatment of hepatocellular carcinoma. World J Hepatol. 2016;8(25):1061\u20136. https:\/\/doi.org\/10.4254\/wjh.v8.i25.1061.","journal-title":"World J Hepatol"},{"issue":"2","key":"2502_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.canlet.2015.12.008","volume":"371","author":"Y Shi","year":"2016","unstructured":"Shi Y, Wang J, Wang Y, et al. A novel mutant 10Ala\/Arg together with mutant 144Ser\/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines. Cancer Lett. 2016;371(2):285\u201391. https:\/\/doi.org\/10.1016\/j.canlet.2015.12.008.","journal-title":"Cancer Lett"},{"key":"2502_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2018.09.043","volume":"133","author":"T Hirschhorn","year":"2019","unstructured":"Hirschhorn T, Stockwell BR. The development of the concept of ferroptosis. Free Radic Biol Med. 2019;133:130\u201343. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.043.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"2502_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1158\/0008-5472.CAN-22-3169","volume":"83","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhao M, Zhao L, et al. HBx-induced HSPA8 stimulates HBV replication and suppresses ferroptosis to support liver cancer progression. Cancer Res. 2023;83(7):1048\u201361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3169.","journal-title":"Cancer Res"},{"issue":"4","key":"2502_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15075","volume":"9","author":"W Zhao","year":"2023","unstructured":"Zhao W, Lei M, Li J, et al. Yes-associated protein inhibition ameliorates liver fibrosis and acute and chronic liver failure by decreasing ferroptosis and necroptosis. Heliyon. 2023;9(4): e15075. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e15075.","journal-title":"Heliyon"},{"issue":"4","key":"2502_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00281-022-00910-2","volume":"44","author":"G Tiegs","year":"2022","unstructured":"Tiegs G, Horst AK. TNF in the liver: targeting a central player in inflammation. Semin Immunopathol. 2022;44(4):445\u201359. https:\/\/doi.org\/10.1007\/s00281-022-00910-2.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"2502_CR16","doi-asserted-by":"publisher","first-page":"8402","DOI":"10.1038\/s41598-021-87812-9","volume":"11","author":"X Cao","year":"2021","unstructured":"Cao X, Zao X, Xue B, et al. The mechanism of TiaoGanYiPi formula for treating chronic hepatitis B by network pharmacology and molecular docking verification. Sci Rep. 2021;11(1):8402. https:\/\/doi.org\/10.1038\/s41598-021-87812-9.","journal-title":"Sci Rep"},{"issue":"4","key":"2502_CR17","doi-asserted-by":"publisher","first-page":"e03068","DOI":"10.1128\/mbio.03068-23","volume":"15","author":"J Tang","year":"2024","unstructured":"Tang J, Zhang J, Zhang G, et al. Stat3 activation-triggered transcriptional networks govern the early stage of HBV-induced hepatic inflammation. MBio. 2024;15(4):e03068-e3123. https:\/\/doi.org\/10.1128\/mbio.03068-23.","journal-title":"MBio"},{"key":"2502_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2022.106936","volume":"107","author":"Y Zou","year":"2022","unstructured":"Zou Y, Xie J, Zheng S, et al. Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery. Int J Surg. 2022;107: 106936. https:\/\/doi.org\/10.1016\/j.ijsu.2022.106936.","journal-title":"Int J Surg"},{"issue":"1","key":"2502_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2502_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/ijms22010213","volume":"22","author":"HW Lee","year":"2021","unstructured":"Lee HW, Lee JS, Ahn SH. Hepatitis B virus cure: targets and future therapies. Int J Mol Sci. 2021;22(1):213. https:\/\/doi.org\/10.3390\/ijms22010213.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2502_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S2468-1253(18)30007-4","volume":"3","author":"MK Maini","year":"2018","unstructured":"Maini MK, Pallett LJ. Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand. Lancet Gastroenterol Hepatol. 2018;3(3):192\u2013202. https:\/\/doi.org\/10.1016\/S2468-1253(18)30007-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"2502_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.canlet.2013.08.035","volume":"345","author":"C Xu","year":"2014","unstructured":"Xu C, Zhou W, Wang Y, Qiao L. Hepatitis B virus-induced hepatocellular carcinoma. Cancer Lett. 2014;345(2):216\u201322. https:\/\/doi.org\/10.1016\/j.canlet.2013.08.035.","journal-title":"Cancer Lett"},{"issue":"23","key":"2502_CR23","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3748\/wjg.v27.i23.3249","volume":"27","author":"PH Almeida","year":"2021","unstructured":"Almeida PH, Matielo CEL, Curvelo LA, et al. Update on the management and treatment of viral hepatitis. World J Gastroenterol. 2021;27(23):3249\u201361. https:\/\/doi.org\/10.3748\/wjg.v27.i23.3249.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2502_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/HEP.0000000000000868","volume":"81","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Chen DP, Chen HD, et al. NK-cell\u2013elicited gasdermin-D\u2013dependent hepatocyte pyroptosis induces neutrophil extracellular traps that facilitate HBV-related acute-on-chronic liver failure. Hepatology. 2025;81(3):917. https:\/\/doi.org\/10.1097\/HEP.0000000000000868.","journal-title":"Hepatology"},{"issue":"5","key":"2502_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1099\/vir.0.19771-0","volume":"85","author":"S Cooray","year":"2004","unstructured":"Cooray S. The pivotal role of phosphatidylinositol 3-kinase\u2013akt signal transduction in virus survival. J Gen Virol. 2004;85(5):1065\u201376. https:\/\/doi.org\/10.1099\/vir.0.19771-0.","journal-title":"J Gen Virol"},{"issue":"2","key":"2502_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/JVI.02440-14","volume":"89","author":"S Rawat","year":"2014","unstructured":"Rawat S, Bouchard MJ. The hepatitis B Virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. J Virol. 2014;89(2):999. https:\/\/doi.org\/10.1128\/JVI.02440-14.","journal-title":"J Virol"},{"issue":"3","key":"2502_CR27","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K\/akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 2003;17(3):590\u2013603. https:\/\/doi.org\/10.1038\/sj.leu.2402824.","journal-title":"Leukemia"},{"issue":"7","key":"2502_CR28","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/j.1742-4658.2012.08514.x","volume":"279","author":"E Khattar","year":"2012","unstructured":"Khattar E, Mukherji A, Kumar V. Akt augments the oncogenic potential of the HBx protein of hepatitis B virus by phosphorylation. FEBS J. 2012;279(7):1220\u201330. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08514.x.","journal-title":"FEBS J"},{"issue":"2","key":"2502_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","volume":"138","author":"AV Pandey","year":"2013","unstructured":"Pandey AV, Fl\u00fcck CE. NADPH P450 oxidoreductase: Structure, function, and pathology of diseases. Pharmacol Ther. 2013;138(2):229\u201354. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.01.010.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2502_CR30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0167-4781(99)00233-X","volume":"1490","author":"TS Smith","year":"2000","unstructured":"Smith TS, Southan C. Sequencing, tissue distribution and chromosomal assignment of a novel ubiquitin-specific protease USP23. Biochim Biophys Acta BBA - Gene Struct Expr. 2000;1490(1):184\u20138. https:\/\/doi.org\/10.1016\/S0167-4781(99)00233-X.","journal-title":"Biochim Biophys Acta BBA - Gene Struct Expr"},{"issue":"5","key":"2502_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0523-z","volume":"9","author":"W Li","year":"2018","unstructured":"Li W, Cui K, Prochownik EV, Li Y. The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth. Cell Death Dis. 2018;9(5):1\u201312. https:\/\/doi.org\/10.1038\/s41419-018-0523-z.","journal-title":"Cell Death Dis"},{"issue":"23","key":"2502_CR32","doi-asserted-by":"publisher","first-page":"6950","DOI":"10.7150\/jca.48998","volume":"11","author":"TB Yang","year":"2020","unstructured":"Yang TB, Yi F, Liu WF, Yang YH, Yang C, Sun J. Identification of hsa_circ_0039053 as an up-regulated and oncogenic circRNA in hepatocellular carcinoma via the miR-637-mediated USP21 activation. J Cancer. 2020;11(23):6950\u20139. https:\/\/doi.org\/10.7150\/jca.48998.","journal-title":"J Cancer"},{"issue":"1","key":"2502_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-020-00214-5","volume":"6","author":"G Song","year":"2020","unstructured":"Song G, Shi Y, Zhang M, et al. Global immune characterization of HBV\/HCV-related hepatocellular carcinoma identifies macrophage and T-cell subsets associated with disease progression. Cell Discov. 2020;6(1):1\u201315. https:\/\/doi.org\/10.1038\/s41421-020-00214-5.","journal-title":"Cell Discov"},{"issue":"11","key":"2502_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100883","volume":"5","author":"Q Bai","year":"2023","unstructured":"Bai Q, Hong X, Lin H, et al. Single-cell landscape of immune cells in human livers affected by HBV-related cirrhosis. JHEP Rep. 2023;5(11): 100883. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100883.","journal-title":"JHEP Rep"},{"issue":"11","key":"2502_CR35","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.3390\/ijms22115497","volume":"22","author":"A Khanam","year":"2021","unstructured":"Khanam A, Chua JV, Kottilil S. Immunopathology of chronic hepatitis B infection: role of innate and adaptive immune response in disease progression. Int J Mol Sci. 2021;22(11):5497. https:\/\/doi.org\/10.3390\/ijms22115497.","journal-title":"Int J Mol Sci"},{"key":"2502_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.721975","author":"I Baudi","year":"2021","unstructured":"Baudi I, Kawashima K, Isogawa M. HBV-specific CD8+ T-cell tolerance in the liver. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.721975.","journal-title":"Front Immunol"},{"issue":"1","key":"2502_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2021.08.029","volume":"76","author":"Y Gao","year":"2022","unstructured":"Gao Y, You M, Fu J, et al. Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B. J Hepatol. 2022;76(1):148\u201359. https:\/\/doi.org\/10.1016\/j.jhep.2021.08.029.","journal-title":"J Hepatol"},{"issue":"2","key":"2502_CR38","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","volume":"67","author":"P Lampertico","year":"2017","unstructured":"Lampertico P, Agarwal K, Berg T, et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370\u201398. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.021.","journal-title":"J Hepatol"},{"issue":"19\u201320","key":"2502_CR39","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1101\/gad.326314.119","volume":"33","author":"P Hou","year":"2019","unstructured":"Hou P, Ma X, Zhang Q, et al. USP21 deubiquitinase promotes pancreas cancer cell stemness via wnt pathway activation. Genes Dev. 2019;33(19\u201320):1361\u20136. https:\/\/doi.org\/10.1101\/gad.326314.119.","journal-title":"Genes Dev"},{"issue":"4","key":"2502_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/embor.2011.17","volume":"12","author":"Y Ye","year":"2011","unstructured":"Ye Y, Akutsu M, Reyes-Turcu F, Enchev RI, Wilkinson KD, Komander D. Polyubiquitin binding and cross-reactivity in the USP domain deubiquitinase USP21. EMBO Rep. 2011;12(4):350\u20137. https:\/\/doi.org\/10.1038\/embor.2011.17.","journal-title":"EMBO Rep"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02502-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02502-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02502-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:35:46Z","timestamp":1744205746000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02502-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02502-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"259"}}